The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke

NCT05663307 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke, Acute

Interventions

DRUG: Ginkgo diterpene lactone meglumine injection
DRUG: Ginkgo diterpene lactone meglumine injection simulation
DRUG: Aspirin

Sponsor

Shanghai Yueyang Integrated Medicine Hospital